↓ Skip to main content

Risk/benefit profile of panitumumab-based therapy in patients with metastatic colorectal cancer: evidence from five randomized controlled trials

Overview of attention for article published in Tumor Biology, July 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
28 Mendeley